Fever Breaking For Momentum Stocks… And Sarepta Surges After FDA Approval 6/21/24
CNBC's "Fast Money"
00:00
Intro
Exploring the recent performance of momentum stocks, a controversial stock prediction on Nike, upcoming financial results, challenges for big banks, and the status of Bitcoin in the current market.
Play episode from 00:00
Transcript
